SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E57CB1C3D121ED50BCD728826FFBA14C26320BEEC8086A066A2C8D69189C36F6898087DBE31B8CBBC0C292DA98E435FB>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E57CB1C3D121ED50BCD728826FFBA14C26320BEEC8086A066A2C8D69189C36F6898087DBE31B8CBBC0C292DA98E435FB
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E57CB1C3D121ED50BCD728826FFBA14C26320BEEC8086A066A2C8D69189C36F6898087DBE31B8CBBC0C292DA98E435FB
http://www.w3.org/2000/01/rdf-schema#comment
"These results provide suggestive evidence of a favorable effect for the XPD 312Asp/Asp and XPD 751Lys/Lys genotypes with respect to overall survival rates in platinum-treated NSCLC patients"
xsd:string
http://purl.uniprot.org/uniprot/#_3EAE9C823BD17EFDA13ACA059D1DEB3A083DA994E58E001044341291279BD0082972741FA8134684BCF41037B3F13DFD
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E57CB1C3D121ED50BCD728826FFBA14C26320BEEC8086A066A2C8D69189C36F6898087DBE31B8CBBC0C292DA98E435FB
http://purl.uniprot.org/uniprot/P32320
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E57CB1C3D121ED50BCD728826FFBA14C26320BEEC8086A066A2C8D69189C36F6898087DBE31B8CBBC0C292DA98E435FB
http://purl.uniprot.org/uniprot/#_P32320-mappedCitation-24841663
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E57CB1C3D121ED50BCD728826FFBA14C26320BEEC8086A066A2C8D69189C36F6898087DBE31B8CBBC0C292DA98E435FB